Circulating endothelial progenitor cells characterization, function and relationship with cardiovascular risk factors.

Since the first description of putative progenitor endothelial cells mobilized from bone marrow by stimuli like ischemia and cytokines, several studies in animals have confirmed their role in neovascularization of ischemic organs. In ischemic myocardium endothelial progenitor cells can prevent cardiomyocyte apoptosis, reduce remodeling and improve cardiac function. These observations led to the hypothesis of endothelial progenitor cells as possible cell-based therapy in patients by autologous transplantation in ischemic tissue or by improving peripheral circulating numbers with mobilization by cytokines. Early trials, including a randomized one, suggest that the intracoronary autologous bone marrow cell transfer after myocardial infarction exerts at least short term functional benefits. Since endothelial damage and dysfunction play a critical role in atherosclerosis disease, research interest was addressed to evaluate the role of progenitor endothelial cells in vascular endothelial layer maintenance. Opposing to local resident endothelial cells poor proliferation rate, progenitor endothelial cells regenerative capacity, homing and integration into blood vessels have been interpreted as a protective role of these cells in vascular homeostasis. Indeed, the number and function of endothelial progenitor cells relate with the progression of atherosclerosis; the accumulation of cardiovascular risk factors or an increased overall risk are inversely associated with endothelial progenitor cells number and function. Finally, recent studies have shown a role of progenitor cells numbers to predict cardiovascular events, raising endothelial progenitor cells to the podium of novel prognostic biomarker.

In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity.

Several natural or synthetic chemicals have been indicated as potential thyroid disruptors. The development of in vitro assays has been recommended to comprehensively assess the potential thyroid disrupting activity of a substance or a complex mixture. In this study, 12 substances suspected for acting as thyroid disruptors were tested for their ability to inhibit TSH-stimulated cAMP production in vitro. Those substances producing an inhibition were further studied to establish the level at which they interfere with this step of thyroid cell function. Using Chinese hamster ovary cells (CHO) transfected with the recombinant human TSH receptor, a dose-dependent inhibition of TSH-stimulated adenylate cyclase activity was produced by 1,1-bis-(4-chlorphenyl)-2,2,2-trichloroethan (DDT), Aroclor 1254 and Melissa Officinalis. All three substances also inhibited the cAMP production stimulated by TSH receptor antibody. Melissa Officinalis produced a significant inhibition of TSH binding to its receptor and of antibody binding to TSH, while no significant changes were produced by Aroclor 1254 or DDT in these assays. These data suggest that principles contained in Melissa Officinalis may block the binding of TSH to its receptor by acting both on the hormone and the receptor itself, while DDT and Aroclor 1254 affect cAMP production mainly at post-receptor step. In conclusion, we have developed a set of in vitro assays that allow investigation into the effect of thyroid disruptors on the TSH-mediated activation of the cAMP cascade. These assays may be useful to identify the mechanism of action of thyroid disruptors, coming beside and supporting animal studies or epidemiological surveys.

Cyclins of phases G1, S and G2/M are overexpressed in aneuploid mammary carcinomas.

Expression of cyclins A, B1 and D1 in human breast cancer was analyzed using dual-parameter flow cytometry with simultaneous evaluation of the DNA content. The asynchronous MCF-7 breast adenocarcinoma cells were used to implement flow cytometry analysis and to analyze the cell cycle distribution of cyclins. The patterns of the cyclin expression were also analyzed in vivo in fresh tissue specimens of human breast carcinomas. The combined measurement of DNA and cyclins showed a higher cyclin expression in aneuploid (11.5 +/- 2.0%, 4.3 +/- 1.1%, and 19.5 +/- 3.4% positive cells for cyclins A, B, and D1, respectively) than in diploid carcinomas (3.9 +/- 1.2%, 1.1 +/- 0.4%, and 5.0 +/- 1.2% positive cells for cyclins A, B, and D1, respectively). A positive relationship was also found between cyclin A and D1 expression and H(3)-thymidine labeling index. In the in vitro model, the asynchronous growing MCF-7 cells showed a variable number of cells expressing cyclins in an unscheduled way, unrelated to the phase at which these cyclins are expressed in normal cells. A similar condition was also observed in tumors. In conclusion, the data showed a deregulated expression of cyclins in a transformed adenocarcinoma cell line and in breast tumors. Furthermore, overexpression of these proteins is related to the aneuploid and high proliferative activity of human mammary carcinomas.

Surface modifications for the development of piezoimmunosensors.

Four different techniques for the immobilisation of proteins onto the gold electrode of a piezoelectric quartz crystal were investigated. The examined techniques were adsorption, avidin-biotin binding and two different types of covalent binding on self-assembled monolayers (SAM), dithiobis(succinimidylpropionate) (DSP) and a dextran modified thiol monolayer. The reaction of the immobilised proteins (bovine serum albumin (BSA) and anti-human IgG) with their specific antibodies, anti-BSA and hIgG (50 and 200 micrograms/ml) were studied using a quartz crystal microbalance and then compared. Many cycles of measurements were performed on the same crystal regenerating the gold surface with a solution of glycine.HCl, 100 mM, pH 2.1. The interactions of the immobilised reagents with non-specific antibodies were also studied. The adsorption protocol was the quickest, but did not allow regeneration with glycine.HCl. Thiol-dextran coated surfaces did not show any detectable response to non-specific reagents, but needed a very long and complicated protocol. DSP and avidin-biotin coating procedures were easy and not too long. They seemed to have the best characteristics of reproducibility among different crystals and possibility of regeneration of the coated surface, but the percentage of non-specific binding was high.

Enzyme electrode for glucose determination in whole blood.

The development of a glucose sensor suitable for use with whole blood is described. It is based on anodic oxidation at +700 mV of hydrogen peroxide with a platinum electrode covered with a gas permeable membrane. Glucose reacts with glucose oxidase immobilised on the external side of the membrane, and forms hydrogen peroxide which is able to cross the gas permeable membrane due to its high vapour tension, while other electroactive substances that are important interferents are completely blocked. This principle was discovered several years ago but no practical application was presented up to now. Therefore in this work a number of different commercial membranes were tested, in order to obtain a resistant, rapidly responding and interference free sensor to be used in conjunction with a blood gas measurement apparatus. Coimmobilisation of glucose oxidase and catalase was found to be useful for fast response and recovery of the electrode. Using some of the tested membranes, the linearity range is 1-15 mM, CV 5%, response time 90 s, recovery time for the next sample 120 s. The membrane's working life is 2-3 weeks.